COVID-19 impact measures for general practice

This document presents an overview of the collaborative project COVID-19 – utilising near real-time electronic Australian general practice data to establish effective care and best-practice policy, including a summary of the Snapshot series which informed the development of a suite of ten impact measures namely:

Impact Measure 1 – Medication prescribing volumes
Impact Measure 2 – Telehealth consultation in general practice, its use and patient factors
Impact Measure 3 – Pathology test request volumes
Impact Measure 4 – Non-acute respiratory illness testing volumes and demographics
Impact Measure 5 – Proportion of telehealth consultations in residential aged care facilities
Impact Measure 6 – HbA1c monitoring in type 2 diabetes – HbA1c testing volume
Impact Measure 7 – HbA1c monitoring in type 2 diabetes- HbA1c testing frequency and HbA1c levels
Impact Measure 8 – Cancer screening in general practice
Impact Measure 9 – Pathology referrals during telehealth consultations
Impact Measure 10 – Mental health consultation volumes

Suggested Citation:Thomas J, Georgiou A, Imai C, Sezgin G, Hardie R-A, Dai Z, Wabe N, Franco G, Li J. Monitoring the impact of COVID-19 on general practice: A suite of impact measures for Australian general practice. Australian Institute of Health Innovation, Macquarie University, Sydney. February 2022.